SCHEMBL2561891

SCHEMBL2561891

CC1CC(Cl)(c2ccc3c(c2)CNCc2nncn2-3)CC=C1c1cccc(OC(F)(F)F)c1

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.36
CBL P22681 1/20 0.33
CBLB Q13191 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2559141 0.86 OPRK1 (0.35)
SCHEMBL2559968 0.84 HSD11B1 (0.37) HSD11B1
Hydrochloric Acid SCHEMBL2558784 0.83 HSD11B1 (0.37) HSD11B1
SCHEMBL2548318 0.81 OPRK1 (0.30)
Hydrochloric Acid SCHEMBL2556738 0.78 AVPR1A (0.31)
Hydrochloric Acid SCHEMBL2545069 0.78 HSD11B1 (0.34) HSD11B1
SCHEMBL2340647 0.72
Hydrochloric Acid SCHEMBL2472001 0.71 SLC6A2 (0.37)
Hydrochloric Acid SCHEMBL2343207 0.70
Hydrochloric Acid SCHEMBL2559362 0.70 OPRK1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558467-A1 ARYL - /HETEROARYL - CYCLOHEXENYL - TETRAAZABENZO [E]AZULENES AS VASOPRESSIN ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2013-02-20 EP claimed
WO-2011128265-A1 ARYL - /HETEROARYL - CYCLOHEXENYL - TETRAAZABENZO [E] AZULENES AS VASOPRESSIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO claimed
EP-2558467-A1 ARYL - /HETEROARYL - CYCLOHEXENYL - TETRAAZABENZO [E]AZULENES AS VASOPRESSIN ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2013-02-20 EP disclosed
WO-2011128265-A1 ARYL - /HETEROARYL - CYCLOHEXENYL - TETRAAZABENZO [E] AZULENES AS VASOPRESSIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO disclosed